Michael A. Egan
Corporate Officer/Principal en Profectus BioSciences, Inc. .
Perfil
Michael A.
Egan is currently the Immunology Director at Profectus BioSciences, Inc. He previously worked as a Principal Research Scientist at Wyeth Research.
Egan received his undergraduate degree from Northern Arizona University and his doctorate from The Johns Hopkins University School of Medicine.
Cargos activos de Michael A. Egan
| Empresas | Cargo | Inicio |
|---|---|---|
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Corporate Officer/Principal | 01/01/2008 |
Antiguos cargos conocidos de Michael A. Egan.
| Empresas | Cargo | Fin |
|---|---|---|
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Michael A. Egan.
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Northern Arizona University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael A. Egan
